A system of alloantigens that selectively identifies lymph-node lymphocytes

Area of Science:

• Immunology
• Cell Biology
• Alloantigen Systems

Background:

• The Lna-1 (lymph-node alloantigen-1) alloantigen system was defined using specific antisera and cytotoxicity assays.
• In normal mice, Lna-1 is primarily expressed on lymph node cells, distinguishing it from other lymphoid organs.

Purpose of the Study:

• To characterize the Lna-1 alloantigen system and its expression patterns in mouse lymphoid organs.
• To investigate the cellular requirements for Lna-1 expression and differentiation.

Main Methods:

• Utilized a cytotoxicity assay with specific antiserum (BALB.I-H-2j x SWR/J)F1 anti-I.29 ascites cells against B6 lymph-node cells (LNC).
• Examined Lna-1 expression on various lymphoid organs (lymph nodes, thymus, spleen, bone marrow) and in genetically modified mice (congenitally asplenic mice).
• Investigated the inducibility of Lna-1 phenotype on different cell populations.

Main Results:

• Lna-1 is expressed on subpopulations of T and B cells within lymph nodes, comprising 30-40% of the total population.
• The Lna-1 phenotype can be induced on thymus and spleen cells, but not bone marrow cells.
• Congenitally asplenic mice lack Lna-1+ cells in lymph nodes, but their LNC can be induced to express Lna-1, suggesting a role for the spleen in differentiation.

Conclusions:

• The spleen appears essential for the differentiation of Lna-1+ cells from Lna-1- precursors.
• Further research is needed to determine the role of the thymus and the interdependence of T and B cells in Lna-1 expression.
• A proposed T-cell pathway suggests bone marrow cells become Lna-1 inducible in the thymus, then Lna-1+ in the spleen before residing in lymph nodes.